Trandate (Labetalol)

Brand Options

arrow pointer

Brand Name : Trandate

Marketing Authorization Holder : RPH Pharmaceuticals

Prescription Required

 
 

Generic Option

arrow pointer2

Generic Name : Labetalol

Manufactured By : Authorized UK Generic

Prescription Required

 
 

Product Details

Trandate

Information about Trandate (Labetalol)

Trandate is a prescription medication that contains the active ingredient labetalol. It belongs to a class of drugs known as beta-blockers, which help to lower blood pressure by blocking the effects of certain chemicals (such as epinephrine) on the heart and blood vessels. Labetalol has both alpha and beta-blocking properties, which makes it effective for controlling hypertension and certain heart conditions.

Product Highlights

  • Trandate is commonly used to treat high blood pressure, either alone or in combination with other antihypertensive medications.
  • In emergency settings, labetalol may be administered intravenously to rapidly lower blood pressure in severe cases of hypertension.
  • Labetalol is sometimes used to manage heart failure, especially in combination with other heart failure medications.

Key Ingredient

  • Labetalol 

Key Benefits

  • Trandate effectively lowers blood pressure, reducing the risk of complications like stroke, heart attack, and kidney damage.
  • Its ability to block both alpha and beta receptors allows it to reduce heart rate and relax blood vessels, improving blood flow and decreasing the heart's workload.
  • Intravenous labetalol is effective in rapidly reducing blood pressure in acute, severe hypertensive crises.
  • Labetalol is beneficial in treating heart failure as part of a comprehensive management plan, helping to improve symptoms and quality of life.

Direction of Use

  • Trandate is usually taken 1-2 times daily, depending on the prescribed dosage.
  • In hospital settings, labetalol may be administered intravenously under medical supervision, especially during hypertensive emergencies.
  • The exact dosage and frequency depend on the individual’s condition and response to treatment, and should be determined by a healthcare provider.

Safety Concerns

  • Trandate can cause excessive lowering of blood pressure, leading to dizziness, lightheadedness, or fainting, especially after the first dose.
  • Labetalol can cause a slower heart rate, which may require monitoring for symptoms like fatigue, dizziness, or fainting.
  • Liver impairment can affect the metabolism of labetalol. Liver function should be monitored, especially during long-term therapy.
  • Beta-blockers, including labetalol, may worsen asthma or other respiratory conditions by narrowing airways. Caution is advised in patients with these conditions.
  • Caution should be exercised when using labetalol in patients with certain types of heart block or severe bradycardia (slow heart rate).
  • Patients with peripheral vascular disease should use labetalol with caution, as it may affect blood circulation.

Avoid Trandate (Labetalol) If

  • Labetalol may worsen respiratory conditions like asthma, so it should be avoided in these cases.
  • People with certain heart rhythm problems or a slow heart rate (bradycardia) should avoid labetalol unless otherwise directed by their doctor.
  • Labetalol is processed by the liver, so it should be avoided in individuals with significant liver disease or impaired liver function.
  • Individuals with very low blood pressure should not use labetalol, as it can further reduce blood pressure.
  • Labetalol should only be used during pregnancy or breastfeeding if the benefits outweigh the risks, as it can pass through the placenta and into breast milk.


Image Image Image Image